Skip to content
Menu

Piper Sandler Reiterates Overweight on Sight Sciences, Raises Price Target to $12

Benzinga Newsdesk 2 weeks ago

Analyst RatingsNewsReiterationPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Piper Sandler analyst Adam Maeder reiterates Sight Sciences (NASDAQ:SGHT) with a Overweight and raises the price target from $9 to $12.

Piper Sandler analyst Adam Maeder reiterates Sight Sciences (NASDAQ:SGHT) with a Overweight and raises the price target from $9 to $12.

Read at benzinga.com